Rethinking Surgery.
We enable safe and efficient monitoring of tissues during cancer surgery without compromising workflows.
Surgeons regularly face problems during cancer surgery:
Tumour cells
left undetected
Healthy tissues
unnecessarily resected
Operative workflows
are complex
Marginum enables unforeseen manual control by detecting tumours from surgical suction waste
Precise detection
of tumour cells
Minimal damage
to healthy tissues
Simplified workflow
at all times
Effortless, near real-time operating Marginum device monitors the surgical suction fluids’ content based on fluorescence intensity.
The surgeon is informed, if any traces of tumour are present in the resected tissue with truly objective and precise feedback.
Safe to use
Hardware-fixed interface with audio feedback from analysis
Design utilises renewable materials & production is planned with minimal carbon footprint
Highly sensitive & specific analysis
Technically failsafe
No secondary devices required for utilisation
“During neurosurgical operation, distinguishing healthy brain tissue from malignant tumour is challenging with contemporary methods.”
– Arto Immonen
Department Chief Physician,
Kuopio University Hospital
”Monitoring of various fluorescent biomarkers in resected cancer tissue aspirates will be a breakthrough in oncological surgery.”
– Juha E Jääskeläinen
Professor & Medical Council,
Kuopio University Hospital
22.3.2023 | Marginum News
Marginum Ltd has initiated its first-in-human clinical trials with the aspirate tissue monitor at the Kuopio University Hospital.
21.2.2023 | Tahko Ski Lift Pitch
Tahko Ski Lift Pitch winner Marginum is pioneering optic tissue monitoring with groundbreaking innovation borne from multidisciplinary UEF research.
10.10.2022 | Kuopio Chamber of Commerce
Marginum joins Kuopio Chamber of Commerce and the Finnish Startup Community after winning Tahko Ski Lift Pitch 2022.
4.10.2022 | University of Eastern Finland
Marginum has been nominated by University of Eastern Finland (UEF) to participate at Stage Two competition in Berlin.
13.9.2022 | Kuopio Health
Marginum joined Kuopio Health to further connect with research institutions and other member companies in the medical technology industry.
6.9.2022 | Tekniikka&Talous
Cancerous tissue could be completely removed in the first operation. In this story, we’ll tell you what Marginum’s device is all about.
Marginum is a medical device company based in Kuopio, Finland.
We prioritize patient welfare and aim to improve surgical outcomes with unique tissue sensing techniques.
The team consists of multidisciplinary experts dedicated to improving pre-existent surgical workflows with data-driven solutions.
Contact us and learn more about the next steps
of our mission.
Location: Kuopio, Finland
Email: info@marginum.com
